vs

Side-by-side financial comparison of Elme Communities (ELME) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

Elme Communities is the larger business by last-quarter revenue ($62.1M vs $44.6M, roughly 1.4× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). PACIFIC BIOSCIENCES OF CALIFORNIA, INC. runs the higher net margin — -90.4% vs -198.9%, a 108.5% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 1.7%). Elme Communities produced more free cash flow last quarter ($7.2M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 2.7%).

Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ELME vs PACB — Head-to-Head

Bigger by revenue
ELME
ELME
1.4× larger
ELME
$62.1M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+12.1% gap
PACB
13.8%
1.7%
ELME
Higher net margin
PACB
PACB
108.5% more per $
PACB
-90.4%
-198.9%
ELME
More free cash flow
ELME
ELME
$27.2M more FCF
ELME
$7.2M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
2.7%
ELME

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ELME
ELME
PACB
PACB
Revenue
$62.1M
$44.6M
Net Profit
$-123.5M
$-40.4M
Gross Margin
61.1%
37.1%
Operating Margin
-183.3%
-92.3%
Net Margin
-198.9%
-90.4%
Revenue YoY
1.7%
13.8%
Net Profit YoY
-4058.7%
-1802.7%
EPS (diluted)
$-1.40
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELME
ELME
PACB
PACB
Q4 25
$44.6M
Q3 25
$62.1M
$38.4M
Q2 25
$62.1M
$39.8M
Q1 25
$61.5M
$37.2M
Q4 24
$61.3M
$39.2M
Q3 24
$61.1M
$40.0M
Q2 24
$60.1M
$36.0M
Q1 24
$59.5M
$38.8M
Net Profit
ELME
ELME
PACB
PACB
Q4 25
$-40.4M
Q3 25
$-123.5M
$-38.0M
Q2 25
$-3.6M
$-41.9M
Q1 25
$-4.7M
$-426.1M
Q4 24
$-3.0M
$2.4M
Q3 24
$-3.0M
$-60.7M
Q2 24
$-3.5M
$-173.3M
Q1 24
$-3.6M
$-78.2M
Gross Margin
ELME
ELME
PACB
PACB
Q4 25
37.1%
Q3 25
61.1%
41.4%
Q2 25
63.5%
36.9%
Q1 25
64.2%
-3.7%
Q4 24
62.9%
25.6%
Q3 24
63.5%
25.0%
Q2 24
63.4%
16.5%
Q1 24
63.5%
29.1%
Operating Margin
ELME
ELME
PACB
PACB
Q4 25
-92.3%
Q3 25
-183.3%
-101.1%
Q2 25
9.6%
-112.8%
Q1 25
7.8%
-1154.5%
Q4 24
10.4%
-390.1%
Q3 24
11.0%
-160.3%
Q2 24
9.8%
-488.3%
Q1 24
7.5%
-209.6%
Net Margin
ELME
ELME
PACB
PACB
Q4 25
-90.4%
Q3 25
-198.9%
-98.9%
Q2 25
-5.7%
-105.4%
Q1 25
-7.6%
-1146.8%
Q4 24
-4.9%
6.0%
Q3 24
-4.9%
-151.9%
Q2 24
-5.8%
-481.3%
Q1 24
-6.1%
-201.4%
EPS (diluted)
ELME
ELME
PACB
PACB
Q4 25
$-0.11
Q3 25
$-1.40
$-0.13
Q2 25
$-0.04
$-0.14
Q1 25
$-0.05
$-1.44
Q4 24
$-0.04
$-0.44
Q3 24
$-0.03
$-0.22
Q2 24
$-0.04
$-0.64
Q1 24
$-0.04
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELME
ELME
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$7.1M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$908.9M
$5.3M
Total Assets
$1.7B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELME
ELME
PACB
PACB
Q4 25
$279.5M
Q3 25
$7.1M
$298.7M
Q2 25
$4.8M
$314.7M
Q1 25
$6.4M
$343.1M
Q4 24
$6.1M
$389.9M
Q3 24
$4.8M
$471.1M
Q2 24
$5.6M
$509.8M
Q1 24
$4.2M
$561.9M
Stockholders' Equity
ELME
ELME
PACB
PACB
Q4 25
$5.3M
Q3 25
$908.9M
$36.1M
Q2 25
$1.0B
$61.5M
Q1 25
$1.1B
$91.6M
Q4 24
$1.1B
$506.6M
Q3 24
$1.1B
$453.1M
Q2 24
$1.1B
$492.7M
Q1 24
$1.1B
$649.0M
Total Assets
ELME
ELME
PACB
PACB
Q4 25
$784.1M
Q3 25
$1.7B
$803.2M
Q2 25
$1.8B
$825.5M
Q1 25
$1.8B
$860.8M
Q4 24
$1.8B
$1.3B
Q3 24
$1.9B
$1.5B
Q2 24
$1.9B
$1.5B
Q1 24
$1.9B
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELME
ELME
PACB
PACB
Operating Cash FlowLast quarter
$15.9M
$-19.1M
Free Cash FlowOCF − Capex
$7.2M
$-19.9M
FCF MarginFCF / Revenue
11.6%
-44.6%
Capex IntensityCapex / Revenue
14.0%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$86.7M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELME
ELME
PACB
PACB
Q4 25
$-19.1M
Q3 25
$15.9M
$-18.7M
Q2 25
$29.8M
$-29.4M
Q1 25
$16.2M
$-44.1M
Q4 24
$95.2M
$-30.6M
Q3 24
$20.7M
$-45.5M
Q2 24
$28.9M
$-54.3M
Q1 24
$21.2M
$-75.7M
Free Cash Flow
ELME
ELME
PACB
PACB
Q4 25
$-19.9M
Q3 25
$7.2M
$-18.8M
Q2 25
$21.1M
$-29.9M
Q1 25
$10.5M
$-45.4M
Q4 24
$47.9M
$-32.3M
Q3 24
$8.8M
$-46.3M
Q2 24
$21.0M
$-55.7M
Q1 24
$7.6M
$-79.6M
FCF Margin
ELME
ELME
PACB
PACB
Q4 25
-44.6%
Q3 25
11.6%
-48.9%
Q2 25
34.1%
-75.3%
Q1 25
17.1%
-122.3%
Q4 24
78.1%
-82.3%
Q3 24
14.4%
-115.7%
Q2 24
34.9%
-154.8%
Q1 24
12.8%
-205.0%
Capex Intensity
ELME
ELME
PACB
PACB
Q4 25
1.9%
Q3 25
14.0%
0.2%
Q2 25
14.0%
1.4%
Q1 25
9.2%
3.7%
Q4 24
77.4%
4.1%
Q3 24
19.4%
2.0%
Q2 24
13.1%
4.1%
Q1 24
22.9%
10.0%
Cash Conversion
ELME
ELME
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELME
ELME

Residential Segment$57.7M93%
Other$4.4M7%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons